Insider · CIK 0001567160

Gano Kyle

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001567160

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-11	NBIXNEUROCRINE BIOSCIENCES INCA Award	Director, Chief Executive Officer	AAward	+6,275 sh	—	—	157,266
2026-09-11	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−3,386 sh	$156.22	−$529K	153,880
2026-09-11	NBIXNEUROCRINE BIOSCIENCES INCA Award	Director, Chief Executive Officer	AAward	+1,842 sh	—	—	155,722
2026-09-11	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−994 sh	$156.22	−$155K	154,728
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,241 sh	—	—	146,254
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,210 sh	$124.12	−$150K	145,044
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,566 sh	—	—	147,610
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,385 sh	$124.12	−$172K	146,225
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCA Award	Director, Chief Executive Officer	AAward	+9,968 sh	—	—	156,193
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−5,378 sh	$124.12	−$668K	150,815
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,241 sh	—	—	4,484
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,566 sh	—	—	2,566
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Stock OptionA Award	Director, Chief Executive Officer	AAward	+115K sh	—	—	114,830
2026-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+20.1K sh	—	—	20,142
2026-02-12	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+4,907 sh	—	—	146,661
2026-02-12	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−2,648 sh	$123.10	−$326K	144,013
2026-02-12	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−4,907 sh	—	—	14,721
2026-01-31	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,927 sh	—	—	143,334
2026-01-31	NBIXNEUROCRINE BIOSCIENCES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,580 sh	$136.06	−$215K	141,754
2026-01-31	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,927 sh	—	—	0
2026-01-16	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+34.6K sh	$35.99	+$1.24M	174,995
2026-01-16	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−34.6K sh	$132.70	−$4.59M	140,407
2026-01-16	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,812 sh	$35.99	+$65.2K	142,219
2026-01-16	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−1,812 sh	$132.71	−$240K	140,407
2026-01-16	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−34.6K sh	—	—	0
2026-01-16	NBIXNEUROCRINE BIOSCIENCES INC · Incentive Stock OptionM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,812 sh	—	—	0
2025-11-04	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−300 sh	$141.97	−$42.6K	140,407
2025-11-01	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+613 sh	—	—	140,720
2025-11-01	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−613 sh	—	—	1,842
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,566 sh	—	—	140,224
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−1,352 sh	$116.84	−$158K	138,872
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,241 sh	—	—	141,113
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−1,206 sh	$116.86	−$141K	139,907
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,566 sh	—	—	5,132
2025-02-13	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,241 sh	—	—	6,725
2025-02-12	NBIXNEUROCRINE BIOSCIENCES INC · Stock OptionA Award	Director, Chief Executive Officer	AAward	+105K sh	—	—	104,736
2025-02-12	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+19.6K sh	—	—	19,628
2025-02-10	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−980 sh	$118.39	−$116K	137,658
2025-02-08	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,860 sh	—	—	138,638
2025-02-08	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,860 sh	—	—	0
2025-01-31	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,927 sh	—	—	138,319
2025-01-31	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−1,541 sh	$152.87	−$236K	136,778
2025-01-31	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,927 sh	—	—	2,927
2025-01-15	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+4,812 sh	$32.99	+$159K	140,204
2025-01-15	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−4,812 sh	$141.50	−$681K	135,392
2025-01-15	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+60.2K sh	$32.99	+$1.99M	195,580
2025-01-15	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director, Chief Executive Officer	SSale	−60.2K sh	$141.50	−$8.52M	135,392
2025-01-15	NBIXNEUROCRINE BIOSCIENCES INC · Incentive Stock OptionM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−4,812 sh	—	—	0
2025-01-15	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−60.2K sh	—	—	0
2024-11-01	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+2,455 sh	—	—	2,455

Recent filings

Accepted (ET)
Sep 154
Gano Kyle0001567160-26-000009
SEC(opens sec.gov)
Feb 174
Gano Kyle0001567160-26-000007
SEC(opens sec.gov)
Feb 34
Gano Kyle0001567160-26-000005
SEC(opens sec.gov)

Companies

NEUROCRINE BIOSCIENCES INCDirector, Chief Executive OfficerNBIX

Address

6027 EDGEWOOD BEND CT.

SAN DIEGO, CA, 92130